Andere Sprachen Biosenta Inc.

Aktien

A2JCLV

CA09072N2023

ZRO

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 21:52:11 29.04.2024			% 5 Tage	% 1. Jan.
0.32 ^CAD	0.00%		-9.86%	+45.45%

27.03.	Biosenta Inc. gibt den erfolgreichen Start einer Produktionsanlage im Labormaßstab bekannt	CI
29.02.	Biosenta Inc. meldet Ergebnis für das erste Quartal zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Biosenta Closes Private Placement Financing	27.04.
Biosenta Inc. announced that it has received CAD 0.6 million in funding	26.04.
Biosenta Announces Private Placement Financing	19.04.
Biosenta Inc. announced that it expects to receive CAD 0.6 million in funding	19.04.
Biosenta Inc. Announces Successful Launch of Bench Scale Production Plant	27.03.
Biosenta Announces Successful Launch of Bench Scale Production Plant and Exceeding Expectations of Tri-Filler(TM) Particle Encapsulation Technology	27.03.
Biosenta Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	29.02.
Amarvir Gill Holdings in Biosenta Inc.	22.02.
Biosenta Announces Closing of Previously Announced Transaction	21.02.
Biosenta Announces Debt Settlement	31.01.
Biosenta Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	29.01.
Biosenta Announces Engagement of Oak Hill Financial Inc.	11.01.
Biosenta Closes Private Placement Financing	27.12.
Biosenta Inc. announced that it has received CAD 0.5 million in funding	27.12.
Biosenta Announces Private Placement Financing	15.12.
Biosenta Inc. announced that it expects to receive CAD 0.5 million in funding	15.12.
Biosenta Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler™ in Collaboration with Dr. Ian Lewis and Dr. Maen Husein's Labs	28.09.23
Biosenta Inc. Announces Breakthrough Discovery in Anti-Microbial Efficacy of Tri-Filler in Collaboration with University of Calgary	28.09.23
Biosenta builds on partnership with AMPAK to test and commercialize Tri-Filler™	06.09.23
Biosenta Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2023	29.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Biosenta Inc.

Aktien

A2JCLV

CA09072N2023

ZRO

Andere Sprachen

Filter